BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Miramar Labs Names Zoromski as CEO


10/14/2008 7:01:58 AM

MENLO PARK, Calif., Oct. 13 /PRNewswire/ -- Miramar Labs (http://www.miramarlabs.com/), a startup dermatologic medical device company based in Menlo Park, CA, has named Darrell Zoromski as President and CEO. Zoromski joins Miramar from Align Technology, where he was Chief Marketing Officer and Global Vice President. Align is a global manufacturer and distributor of Invisalign-branded aligner trays that straighten teeth.

"Darrell brings an impressive record of entrepreneurial marketing leadership to Miramar," says Mark Deem, Interim President & CEO of Miramar and Chief Technology Officer of The Foundry, where Miramar Labs was incubated. Prior to his position at Align, Zoromski held marketing management positions of increasing responsibilities at Sola/Zeiss Vision Company, Pillsbury, S.C. Johnson, and Proctor & Gamble. Notes Deem: "At each stop in his career, Darrell has led the establishment of innovative new technologies while growing market share and profitability." Zoromski is a graduate of the Kellogg Graduate School of Management at Northwestern University, where he earned is MBA in marketing, and of the University of Wisconsin, where he earned his BA in finance, international business and marketing.

Miramar was launched in 2006 with a Series "A" round financing of $5 million from The Foundry's two venture capital backers, Morgenthaler Ventures and Split Rock Partners. In February 2008, Domain Associates led a "B" round financing of $22-million, in which Morgenthaler, and Split Rock also invested.

Miramar represents the 11th company incubated at The Foundry (www.the-foundry.com), widely recognized as the world's premier medical device incubator. Founded in 1998, The Foundry has created such companies as Concentric Medical, Emphasys, Evalve, Satiety, Xtent, which have combined valuations of over $1-billion and employ more than 600 people.

Source: Miramar Labs

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES